annonacin
annonacin Basic information
- Product Name:
- annonacin
- Synonyms:
-
- annonacin
- (5S)-5-Methyl-3-[(2R,8R,13R)-2,8,13-trihydroxy-13-[[(2R)-tetrahydro-5α-[(R)-1-hydroxytridecyl]furan]-2β-yl]tridecyl]-2(5H)-furanone
- 2(5H)-Furanone, 5-methyl-3-[(2R,8R,13R)-2,8,13-trihydroxy-13-[(2R,5R)-tetrahydro-5-[(1R)-1-hydroxytridecyl]-2-furanyl]tridecyl]-, (5S)-
- (+/-) Annonacin (Mixture of Isomers)
- CAS:
- 111035-65-5
- MF:
- C35H64O7
- MW:
- 596.88
- Mol File:
- 111035-65-5.mol
More
Less
annonacin Chemical Properties
- Melting point:
- 69-71 °C
- Boiling point:
- 756.2±55.0 °C(Predicted)
- Density
- 1.050±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMF: 10 mg/ml; DMSO: 20 mg/ml; DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml; Ethanol: 1 mg/ml
- form
- A powder
- pka
- 14.45±0.20(Predicted)
- color
- White to off-white
- InChIKey
- XNODZYPOIPVPRF-CGWDHHCXSA-N
- SMILES
- O1[C@@H](C)C=C(C[C@H](O)CCCCC[C@@H](O)CCCC[C@@H](O)[C@H]2CC[C@H]([C@H](O)CCCCCCCCCCCC)O2)C1=O
More
Less
annonacin Usage And Synthesis
Uses
(+/-) Annonacin is used as a modulation of cancer signaling pathway(s) in two -stage mouse skin tumorigenesis by annonacin. Its also used in the evaluation of nutritional characteristics and bioactive compounds of Annona muricata-yogurt and Annona muricata-frozen dessert.
in vivo
Annonacin (0-9 mg/kg; Subcutaneous osmotic pump; 3 days) increases tau phosphorylation in R406W+/+ mice [3].
Annonacin (85 nM/100 μL; Topical application; Twice a week for 22 weeks) has anti-cancer effect in mouse model of skin tumor [4].
| Animal Model: | R406W+/+ transgenic mice[3] |
| Dosage: | 0, 6 and 9 mg/kg/day |
| Administration: | Subcutaneous osmotic pump; 3 days |
| Result: | Increased the number of neurons with phosphorylated tau in the somatodendritic compartment in several brain areas. Increased the levels of phosphorylated tau protein. Increased in total tau protein without increase in tau mRNA, but reduced proteasomal proteolytic activity. Increased the levels of different tau kinases. Significantly increased the ratio of p25/p35. |
| Animal Model: | DMBA (HY-W011845)/TPA treated female ICR mice aged 6-7 weeks old[4] |
| Dosage: | 85 nM/100 uL |
| Administration: | Topical application; Twice a week for 22 weeks |
| Result: | Significantly increased the tumor latency period and reduced the tumor incidence, tumor burden and tumor volume, respectively. Suppressed tumorigenesis manifested by significant reduction of hyperkeratosis, dermal papillae and number of keratin pearls on skin tissues. Showed no toxicity to the liver and kidneys. |
annonacinSupplier
BioBioPha Co., Ltd. Gold
- Tel
- 0871-65217109 13211707573;
- y.liu@mail.biobiopha.com
Sichuan BioCrick Biotech Co., Ltd Gold
- Tel
- 28-86-28-8543-3893 13260669172
- sales@biocrick.com
Chembest Research Laboratories Limited
- Tel
- +86-21-20908456
- sales@BioChemBest.com
Sichuan Wei Keqi Biological Technology Co., Ltd.
- Tel
- 028-81700200 18116577057
- 3003855609@qq.com
Wuxi Zhongkun Biochemical Technology Co., Ltd.
- Tel
- 0510-85629785 18013409632
- sales@reading-chemicals.com